Rocket Lab Shares Face Pressure as Neutron Rocket Launch Pushed to Next Year

Rocket Lab USA, once a high-flying space sector contender, is confronting significant headwinds as it postpones the inaugural launch of its Neutron rocket. This schedule adjustment into the following calendar year has triggered a sell-off, compelling investors to assess whether this is a temporary setback or indicative of a more profound strategic challenge for the ambitious space enterprise.

Soaring Valuation Meets Operational Reality

Beyond the immediate news of the launch delay lies a more fundamental concern: the company’s stretched valuation. Rocket Lab’s stock currently trades at a price-to-sales (P/S) multiple exceeding 41. This figure towers almost four times above the industry average, placing the sustainability of its market valuation under intense scrutiny.

While some market researchers maintain long-term price targets as high as $58, the substantial premium appears increasingly difficult to justify in light of recent operational hurdles.

Key valuation concerns include:
* A sales multiple that is 14 times greater than the sector average.
* Trading significantly above a considered fair-value multiple of 7.5x.
* A market capitalization that appears disconnected from the company’s current revenue-generating capabilities.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Defense Contracts Provide a Strategic Cushion

Amid the negative sentiment surrounding the Neutron program, Rocket Lab’s defense division continues to demonstrate robust performance. The company just this week successfully completed its sixth HASTE mission for the U.S. Department of Defense, achieving this milestone a mere 14 months after the initial contract was signed. This proven ability to deliver for government clients rapidly and reliably offers a crucial buffer of stability during periods of volatility for its core commercial launch business.

Record Revenue Obscures Persistent Challenges

The company’s third-quarter earnings report did highlight record revenues and a marked increase in the number of Electron rocket launches. However, the path to sustained profitability remains arduous. Soaring research and development expenditures dedicated to the Neutron rocket continue to compress profit margins. This financial pressure is unlikely to ease until a definitive and successful launch timeline for the Neutron vehicle is established.

Despite the recent downturn, a longer-term perspective reveals a remarkable performance. When viewed over a three-year horizon, Rocket Lab shares have delivered an astounding 881 percent gain. For investors with a patient outlook and a conviction in the company’s ability to ultimately overcome its technical challenges, the current price correction may present a potential entry point.